Two Sigma Investments, LP Revance Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

  • $40.3 Billion
  • Q1 2024

A detailed history of Two Sigma Investments, LP transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 257,397 shares of RVNC stock, worth $661,510. This represents 0.0% of its overall portfolio holdings.

Number of Shares
257,397
Holding current value
$661,510
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$4.65 - $9.31 $1.2 Million - $2.4 Million
257,397 New
257,397 $1.27 Million
Q2 2023

Aug 14, 2023
SELL
$24.7 - $37.61 $13.8 Million - $21 Million
-557,499 Reduced 40.56%
816,839 $20.7 Million
Q1 2023

May 15, 2023
BUY
$18.36 - $35.27 $425,658 - $817,699
23,184 Added 1.72%
1,374,338 $44.3 Million
Q4 2022

Feb 14, 2023
BUY
$18.32 - $30.66 $4.2 Million - $7.03 Million
229,331 Added 20.44%
1,351,154 $24.9 Million
Q3 2022

Nov 14, 2022
BUY
$14.33 - $28.47 $11.1 Million - $22.1 Million
777,135 Added 225.46%
1,121,823 $30.3 Million
Q2 2022

Aug 15, 2022
BUY
$11.52 - $20.4 $2.71 Million - $4.8 Million
235,292 Added 215.08%
344,688 $4.76 Million
Q1 2022

May 16, 2022
BUY
$12.36 - $20.31 $254,492 - $418,182
20,590 Added 23.19%
109,396 $2.13 Million
Q4 2021

Feb 14, 2022
BUY
$12.46 - $27.87 $1.11 Million - $2.48 Million
88,806 New
88,806 $1.45 Million
Q4 2020

Feb 16, 2021
SELL
$23.41 - $28.34 $766,022 - $927,341
-32,722 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$23.23 - $34.3 $455,609 - $672,725
19,613 Added 149.61%
32,722 $823,000
Q2 2020

Aug 14, 2020
SELL
$12.6 - $26.55 $1.45 Million - $3.05 Million
-114,858 Reduced 89.76%
13,109 $320,000
Q1 2020

May 15, 2020
BUY
$12.46 - $27.81 $947,769 - $2.12 Million
76,065 Added 146.56%
127,967 $1.89 Million
Q4 2019

Feb 14, 2020
BUY
$11.66 - $20.15 $605,177 - $1.05 Million
51,902 New
51,902 $842,000
Q3 2019

Nov 14, 2019
SELL
$10.22 - $14.5 $370,393 - $525,509
-36,242 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$10.67 - $15.49 $861,815 - $1.25 Million
-80,770 Reduced 69.03%
36,242 $470,000
Q1 2019

May 15, 2019
BUY
$15.4 - $20.39 $1.8 Million - $2.39 Million
117,012 New
117,012 $1.84 Million
Q4 2018

Feb 14, 2019
SELL
$18.06 - $24.96 $705,044 - $974,413
-39,039 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$23.55 - $30.1 $2.51 Million - $3.21 Million
-106,638 Reduced 73.2%
39,039 $970,000
Q2 2018

Aug 14, 2018
BUY
$27.45 - $33.35 $2.69 Million - $3.26 Million
97,822 Added 204.41%
145,677 $4 Million
Q1 2018

May 15, 2018
SELL
$29.15 - $37.4 $1.06 Million - $1.36 Million
-36,287 Reduced 43.13%
47,855 $1.47 Million
Q4 2017

Feb 14, 2018
BUY
$24.55 - $36.3 $2.07 Million - $3.05 Million
84,142
84,142 $3.01 Million

Others Institutions Holding RVNC

# of Institutions
214
Shares Held
83.4M
Call Options Held
656K
Put Options Held
424K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email